Activation of tolerogenic dendritic cells in the tumor draining lymph nodes by CD8+ T cells engineered to express CD40 ligand.
about
Dendritic cell-based vaccine efficacy: aiming for hot spotsImmune-based antitumor effects of BRAF inhibitors rely on signaling by CD40L and IFNγ.Enhancing antitumor efficacy of chimeric antigen receptor T cells through constitutive CD40L expression.T cells as vehicles for cancer vaccinationMultiple effects of CD40–CD40L axis in immunity against infection and cancer.
P2860
Activation of tolerogenic dendritic cells in the tumor draining lymph nodes by CD8+ T cells engineered to express CD40 ligand.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Activation of tolerogenic dend ...... neered to express CD40 ligand.
@ast
Activation of tolerogenic dend ...... neered to express CD40 ligand.
@en
type
label
Activation of tolerogenic dend ...... neered to express CD40 ligand.
@ast
Activation of tolerogenic dend ...... neered to express CD40 ligand.
@en
prefLabel
Activation of tolerogenic dend ...... neered to express CD40 ligand.
@ast
Activation of tolerogenic dend ...... neered to express CD40 ligand.
@en
P2093
P2860
P356
P1476
Activation of tolerogenic dend ...... neered to express CD40 ligand.
@en
P2093
Eileen M Higham
Jianzhu Chen
K Dane Wittrup
P2860
P304
P356
10.4049/JIMMUNOL.0903111
P407
P577
2010-03-03T00:00:00Z